New additional data from the phase 3 TALAPRO-2 study, presented today at the 2023 Annual Meeting of the American Society of…
Led by VHIO’s César Serrano, alongside first author Jonathan C. Trent at the Sylvester Comprehensive Cancer Center in Miami, an…
Presented today by VHIO’s Ana Oaknin at the 2023 ASCO Annual Meeting, 2-6 June (Chicago, IL), updated dose expansion data…
Published in The New England Journal of Medicine (1) results of the phase 3 COSMIC-313 trial show that the addition…
This year’s Scientific Report is themed Advancing cancer care through transformative team science. It celebrates VHIO’s model of multidisciplinary and…
Presented at the 2023 ESMO Breast Cancer Annual Congress, 11-13 May in Berlin, final results of the SOLTI-TOT-HER3 window of…
Liquid biopsy is increasingly stepping up as a non-invasive approach in detecting and tracking circulating tumor DNA (ctDNA) in blood…
The operation was led by the Botin Foundation Mind the Gap programme, with participation from BStartup of Banco Sabadell. The…
Today, the journals Nature and Nature Genetics publish two studies led by Dr Francisco Martínez Jiménez, current head of VHIO’s…
This program aims to encourage the recruitment of young professionals in the research sector. The grants have been awarded within…
The New England Journal of Medicine publishes today the results of the SUNLIGHT study, a Phase III clinical trial comparing…
Published in The New England Journal of Medicine (1), first results of the international POSITIVE study co-authored by VHIO’s Cristina…
